Medical Bulletin 04/May/2026 - Video

Here are the top medical news for today:

Study Confirms AI Can Identify Pancreatic Cancer Much Earlier Than Diagnosis

A silent killer may finally be losing its invisibility. Researchers at Mayo Clinic have developed an artificial intelligence tool that can detect pancreatic cancer years before it is typically diagnosed—potentially transforming outcomes for one of the deadliest cancers.

Published in Gut, the study introduces a system called the Radiomics-based Early Detection Model (REDMOD). Unlike traditional methods that rely on visible tumors, this AI scans routine abdominal CT images to identify subtle, early changes in pancreatic tissue—long before a mass can be seen.

In testing, REDMOD analyzed nearly 2,000 CT scans, including images from patients who were later diagnosed with pancreatic cancer but whose scans had originally been read as normal. The results were striking: the AI detected 73% of these hidden cancers at a median of 16 months before diagnosis—almost twice the detection rate of specialists reviewing the same scans without AI support.

Its advantage was even more pronounced at earlier stages. In scans taken more than two years before diagnosis, the system identified nearly three times as many cancers that would otherwise go unnoticed. This matters because pancreatic cancer is rarely caught early; more than 85% of patients are diagnosed after the disease has already spread, when treatment options are limited.

The technology works by measuring hundreds of imaging features—tiny variations in tissue texture and structure—that signal early biological changes. Importantly, it can run automatically on scans already performed for other reasons, making it especially useful for monitoring high-risk individuals, such as those with new-onset diabetes.

While further validation is needed, this breakthrough points to a future where pancreatic cancer is no longer detected too late—shifting the focus from late-stage treatment to early, potentially life-saving intervention.

REFERENCE: Mukherjee S, Antony A, Patnam NG, et al; Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability; Gut; doi: 10.1136/gutjnl-2025-337266

Researchers Develop Wearable Sensor to Monitor Vitamin Levels Through Sweat

Your sweat could soon double as a real-time nutrition report. In a breakthrough study published in Nature Communications, researchers have developed a wearable device that can track multiple vitamins through sweat—offering a non-invasive way to monitor nutritional health.

Globally, more than 2 billion people experience “hidden hunger,” where calorie intake is sufficient but essential micronutrients are lacking. Traditional blood tests, while accurate, are invasive and impractical for frequent monitoring. This new wearable aims to change that by turning sweat into a continuous source of nutritional data.

The device consists of a flexible skin patch paired with a reusable electronic module. Using advanced electrochemical sensors enhanced with nanomaterials, it can detect extremely low concentrations of key vitamins, including B1, B2, B7, B9 (folate), B12, and vitamin D. Sweat is gently stimulated using a mild electrical current and analyzed in real time, with data transmitted wirelessly to a smartphone.

In human testing, the system successfully tracked changes in vitamin B9 levels after food and supplement intake. After a single dose of folic acid, sweat levels rose more than threefold within hours. Importantly, these readings closely matched blood measurements, showing strong correlation and reliability.

The device also revealed lifestyle-linked differences. For instance, smokers showed lower vitamin B9 levels compared to non-smokers, highlighting its potential for identifying at-risk groups and guiding targeted interventions.

What makes this technology stand out is its ability to deliver continuous, personalized insights. Instead of relying on occasional lab tests, individuals could monitor how diet, supplements, or habits affect their nutrient levels in real time.

By making vitamin tracking easier and more accessible, this innovation could reshape how we manage diet and health—shifting the focus from reactive care to proactive, data-driven wellness.

REFERENCE: Wang, X., Wang, Y., Li, Y., Sun, Y., Mao, P., Liu, S., Ou, J., Wang, X., Ren, F., & Zhang, H. (2026). Real-time nanomolar vitamin monitoring in sweat using an electrochemical skin-attached device. Nature Communications. DOI: 10.1038/s41467-026-72356-1, https://www.nature.com/articles/s41467-026-72356-1

Breakthrough 3D Imaging Reveals How Killer T Cells Destroy Cancer Cells

The body’s most precise assassins just came into sharper focus. In a study published in Cell Reports, researchers from University of Geneva and Lausanne University Hospital have captured an unprecedented 3D view of how cytotoxic T cells attack infected and cancerous cells.

These immune “killer” cells rely on a highly specialized contact point known as the immune synapse—a tightly controlled interface where they release toxic molecules to destroy their target while sparing surrounding healthy tissue.

Using an advanced technique called cryo-expansion microscopy, scientists were able to overcome this barrier. The method rapidly freezes cells to preserve their natural state, then expands them using a hydrogel, allowing researchers to observe internal structures at nanometer-scale resolution without distortion.

What they found reshapes our understanding of how these cells work. At the point of contact, the cell membrane forms a dome-like structure, likely linked to both adhesion and internal organization. This architecture appears to play a critical role in how the cell directs its lethal payload with such precision.

The study also revealed new details about cytotoxic granules—the tiny packets of toxic molecules used to kill target cells. These granules were found to vary in structure, sometimes containing multiple concentrated “cores,” suggesting a more complex and adaptable killing mechanism than previously thought.

Importantly, the researchers extended their observations beyond lab-grown cells to actual human tumor samples. This allowed them to see how T cells behave in real cancer environments, offering insights into why some immune responses succeed while others fail.

Understanding these microscopic interactions could help refine therapies, making cancer treatments more targeted, effective, and personalized in the future.

REFERENCE: Florent Lemaître, Olivier Mercey, Isabelle Mean, Elise Paulin, Valérie Dutoit, Jan A. Rath, Christine von Gunten, Denis Migliorini, Caroline Arber, Paul Guichard, Virginie Hamel, Benita Wolf. Unveiling the molecular architecture of T cells and immune synapses with cryo-expansion microscopy. Cell Reports, 2026; 45 (4): 117165 DOI: 10.1016/j.celrep.2026.117165